Microbial Toxins: Types, Mechanisms of Action, and Pathogenic Significance

• Mayada Abdullah Shehan

  Department of Biology, College of Science, University of Anbar, Ramadi, Anbar

• Sara Imad Hajwal

  Department of Biology, College of Science, University of Anbar, Ramadi, Anbar Iraq

General Background: Microbial toxins are critical virulence factors that contribute to disease by directly damaging host cells or modulating immune responses. Specific Background: Existing classifications, including exotoxins and endotoxins, often fail to integrate structural characteristics with mechanisms of entry, activation, and signaling pathways, particularly in relation to lipopolysaccharide recognition and mycotoxin-related public health concerns. Knowledge Gap: A cohesive framework linking toxin structure, delivery mechanisms, and immunopathological outcomes remains insufficiently developed in current literature. Aims: This review aims to establish an integrated classification of microbial toxins and to elucidate their mechanisms of action across molecular, cellular, and immunological levels. Results: The study identifies key toxin categories, including A–B toxins, membrane-disrupting toxins, superantigens, lipopolysaccharides, and mycotoxins, and outlines core mechanistic principles such as delivery, cellular selectivity, post-entry activation, and signal amplification, leading to inflammation and cell death. It also highlights the role of host variability and microbiota interactions in shaping toxic responses. Novelty: The review proposes a multidimensional framework combining structural, functional, and immunological perspectives to better interpret toxin behavior and disease patterns. Implications: These findings support the development of targeted interventions, including toxin-neutralizing therapies, improved vaccine design, and standardized research approaches for clinical and laboratory applications.

Highlights:
• Integrated framework links toxin structure with delivery and activation processes
• Functional classification connects mechanisms to specific pathological outcomes
• Host variability and microbiota interactions shape toxin-related disease patterns

Keywords: Microbial Toxins, Exotoxins, Endotoxin, Lipopolysaccharide, Mycotoxins

M. R. Popoff, “Overview of bacterial protein toxins from pathogenic bacteria: Mode of action and insights into evolution,” Toxins, vol. 16, no. 4, p. 182, 2024, doi: 10.3390/toxins16040182.

E. Atchade, C. De Tymowski, N. Grall, S. Tanaka, and P. Montravers, “Toxic shock syndrome: A literature review,” Antibiotics, vol. 13, no. 1, p. 96, 2024, doi: 10.3390/antibiotics13010096.

P. Arya, V. Sharma, P. Singh, S. Thapliyal, and M. Sharma, “Bacterial endotoxin-lipopolysaccharide role in inflammatory diseases: An overview,” Iran. J. Basic Med. Sci., vol. 28, no. 5, pp. 553–564, 2025, doi: 10.22038/ijbms.2025.82302.17799.

R. Luo et al., “An examination of the LPS–TLR4 immune response through the analysis of molecular structures and protein–protein interactions,” Cell Commun. Signal., vol. 23, p. 142, 2025, doi: 10.1186/s12964-025-02149-4.

R. Shekhar et al., “A comprehensive review of mycotoxins, their toxicity, and innovative detoxification methods,” Toxicol. Rep., vol. 14, p. 101952, 2025, doi: 10.1016/j.toxrep.2025.101952.

Y. Syraji et al., “Comprehensive review of aflatoxin contamination, its occurrence, effects, management, and future perspectives,” Discover Food, vol. 5, p. 377, 2025, doi: 10.1007/s44187-025-00680-4.

R. Touaitia et al., “Toxic shock syndrome toxin-1 (TSST-1) in Staphylococcus aureus: Prevalence, molecular mechanisms, and public health implications,” Toxins, vol. 17, no. 7, p. 323, 2025, doi: 10.3390/toxins17070323.

H. Jamali, F. Akrami, H. Layeghkhavidaki, and S. Bouakkaz, “Bacterial protein secretion systems: Mechanisms, functions, and roles in virulence,” Microb. Pathog., vol. 206, p. 107790, 2025, doi: 10.1016/j.micpath.2025.107790.

Y. Xiao, Z. Yan, F. Ren, and Y. Tan, “Bacterial exotoxins in medicine: Potential value and perspectives,” Int. J. Med. Sci., vol. 22, no. 9, pp. 2010–2019, 2025, doi: 10.7150/ijms.110104.

D. V. Grebennikova, U. K. Shandilya, and N. A. Karrow, “Beyond TLR4 and its alternative lipopolysaccharide (LPS) sensing pathways in zebrafish,” Genes, vol. 16, no. 9, p. 1014, 2025, doi: 10.3390/genes16091014.

W. Niaz et al., “Mycotoxins: A comprehensive review of global trends in major cereals, advancements in chromatographic detections and future prospects,” Food Chem. X, vol. 27, p. 102350, 2025, doi: 10.1016/j.fochx.2025.102350.

T. M. Nazareth et al., “Comprehensive review of aflatoxin and ochratoxin A dynamics: Emergence, toxicological impact, and advanced control strategies,” Foods, vol. 13, no. 12, p. 1920, 2024, doi: 10.3390/foods13121920.

B. Mendoza-Guido and K. Rojas-Jimenez, “Beyond plasmid addiction: The role of toxin-antitoxin systems in mobile genetic elements,” J. Bacteriol., vol. 207, no. 10, p. e00232-25, 2025, doi: 10.1128/jb.00232-25.

H. Pu et al., “A toxin-antitoxin system provides phage defense via DNA damage and repair,” Nat. Commun., vol. 16, p. 3141, 2025, doi: 10.1038/s41467-025-58540-9.

A. Bahl et al., “Toxin–antitoxin modules: Genetic elements with many faces and functions,” Bacteria, vol. 4, no. 4, p. 61, 2025, doi: 10.3390/bacteria4040061.

L. Jia and L. Zhu, “The bacterial type III secretion system as a broadly applied protein delivery tool in biological sciences,” Microorganisms, vol. 13, no. 1, p. 75, 2025, doi: 10.3390/microorganisms13010075.

D. Barman and R. Drolia, “Caveolin-mediated endocytosis: Bacterial pathogen exploitation and host–pathogen interaction,” Cells, vol. 14, no. 1, p. 2, 2024, doi: 10.3390/cells14010002.

R. Kumar and B. R. Singh, “Botulinum toxin: A comprehensive review of its molecular architecture and mechanistic action,” Int. J. Mol. Sci., vol. 26, no. 2, p. 777, 2025, doi: 10.3390/ijms26020777.

S. Iranpour, M. Arif, and E. Szegezdi, “Disrupting membranes, controlling cell fate: The role of pore-forming proteins in cell death and therapy,” Apoptosis, vol. 30, pp. 1961–1988, 2025, doi: 10.1007/s10495-025-02133-w.

J. B. Fan et al., “The ‘cytokine storm’ in infection and sepsis: Win the battle but lose the war,” Mil. Med. Res., vol. 12, p. 95, 2026, doi: 10.1186/s40779-025-00678-0.

K. Roszak et al., “Endotoxin’s impact on organism: From immune activation to tolerance and beyond,” J. Clin. Med., vol. 14, no. 18, p. 6478, 2025, doi: 10.3390/jcm14186478.

C. Li et al., “The role of polymyxin B-immobilized hemoperfusion in sepsis and septic shock: A meta-analysis,” Heliyon, vol. 10, no. 24, p. e33245, 2024, doi: 10.1016/j.heliyon.2024.e33245.

H. Gómez, “Endotoxin: A bona fide treatable sepsis endotype?,” Blood Purif., early access, 2025, doi: 10.1159/000546294.

F. R. Shepherd et al., “The superantigens SpeC and TSST-1 specifically activate TRBV12-3/12-4+ memory T cells,” Commun. Biol., vol. 6, 2023, doi: 10.1038/s42003-023-04420-1.

S. Parveen et al., “Bacterial pore-forming toxin pneumolysin drives pathogenicity through host extracellular vesicles,” iScience, vol. 27, no. 8, p. 110589, 2024, doi: 10.1016/j.isci.2024.110589.

T. Li et al., “Mycotoxin-caused intestinal toxicity: Underlying molecular mechanisms and future directions,” Toxics, vol. 13, no. 8, p. 625, 2025, doi: 10.3390/toxics13080625.

A. M. Gasperini, D. Faccenda, and E. García-Cela, “Unravelling the impact of mycotoxins on gut health: Implications for inflammatory bowel disease,” Curr. Opin. Food Sci., vol. 64, p. 101316, 2025, doi: 10.1016/j.cofs.2025.101316.

P. Esmaeilnejad-Ahranjani et al., “Detoxification techniques for bacterial toxins: A pathway to effective toxoid vaccines,” Toxicon, vol. 260, p. 108365, 2025, doi: 10.1016/j.toxicon.2025.108365.

A. Khlebnikova et al., “Current progress in the development of mRNA vaccines against bacterial infections,” Int. J. Mol. Sci., vol. 25, no. 23, p. 13139, 2024, doi: 10.3390/ijms252313139.

Á. Lázaro et al., “Probiotics, prebiotics, synbiotics, and postbiotics in the context of emerging mycotoxins and gut microbiota: A systematic review,” Food Funct., vol. 15, no. 19, pp. 8950–8974, 2024, doi: 10.1039/D4FO01705F.

U. B. A. Aziz et al., “Targeted small molecule inhibitors blocking the cytolytic activity of pneumolysin,” Nat. Commun., vol. 15, p. 3738, 2024, doi: 10.1038/s41467-024-47741-3.

M. Duan et al., “Discovery and design of an aptamer that inhibits Shiga toxin: Toward nucleic-acid-based antitoxin strategies,” Int. J. Biol. Macromol., vol. 260, p. 129826, 2024, doi: 10.1016/j.ijbiomac.2024.129826.

T. Iba et al., “Endotoxin activity assay-guided patient selection for polymyxin B hemoperfusion in sepsis and septic shock,” Healthcare, vol. 13, no. 20, p. 2603, 2025, doi: 10.3390/healthcare13202603.

H.-C. Chen, “Monoclonal antibodies as a therapeutic strategy against bacterial infections: Current status and future perspectives,” Life, vol. 14, no. 2, p. 246, 2024, doi: 10.3390/life14020246.

A. Darbandi et al., “Antibody–antibiotic conjugates: A comprehensive review of design strategies and clinical prospects,” J. Clin. Lab. Anal., vol. 38, no. 5, p. e25071, 2024, doi: 10.1002/jcla.25071.

H. Chen, Y. Gu, L. Song, and L. Si, “Next-generation vaccines against bacterial pathogens: mRNA and beyond,” Front. Immunol., vol. 16, p. 1709794, 2025, doi: 10.3389/fimmu.2025.1709794.

M. M. Islam et al., “Gut microorganism-mediated neutralization of mycotoxins: Advances in biological detoxification,” Biomed Res. Int., vol. 2024, p. 8448547, 2024, doi: 10.1155/2024/8448547.

A. M. Deacy, S. K. Gan, and J. P. Derrick, “Superantigen recognition and interactions: Functions, mechanisms and applications,” Front. Immunol., vol. 12, p. 731845, 2021, doi: 10.3389/fimmu.2021.731845.

X. Li et al., “Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis,” EMBO J., vol. 43, pp. 4954–4983, 2024, doi: 10.1038/s44318-024-00237-8.

J. Pławińska-Czarnak, M. Zawadzki, and B. Wróblewska, “Mycotoxin biodegradation by Bacillus bacteria—A review,” Toxins, vol. 16, no. 11, p. 478, 2024, doi: 10.3390/toxins16110478.

S. Vitalini, M. Iriti, and L. Vallone, “Mycotoxins in European Union regulations (2023–2025),” Ital. J. Food Saf., vol. 15, no. 1, p. 14096, 2025, doi: 10.4081/ijfs.2025.14096.